Quality of care for patients hospitalized with heart failure at academic medical centers

American Heart Journal

Volumn 137, Issue 6, 1999, Pages 1028-1034

  Nohria, Anju ^b   Chen, Ya Ting ^b   Morton, David J ^b   Walsh, Robin ^b   Vlasses, Peter H ^b   Krumholz, Harlan M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; FEMALE; HEALTH CARE QUALITY; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT MONITORING; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SMOKING CESSATION; UNIVERSITY HOSPITAL;

EID: 0033427322     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70358-3     Document Type: Article

References (27)

1. Konstam MA, Dracup K, Baker DW, et al. Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. Clinical practice Guideline No. 11. AHCPR Publication No. 94-0612. Rockville, Md, 1995, Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services.
2. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997;157:99-104.
3. Hadorn DC, Baker DW, Kamberg CJ, et al. Phase II of the AHCPR-sponsored heart failure guideline: translating practice recommendations into review criteria Jt Comm J Qual Impr 1996;22:265.
4. Bart BA, Gattis WA, Diem SJ, et al. Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. Am J Cardiol 1997;79:1118-20.
5. Bourassa MG, Gurne O, Bangdiwala SI, et al. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 1993;22:14A-19A.
6. Chin MH, Goldman L. Factors contributing to the hospitalizations of patients with congestive heart failure. Am J Public Health 1997;87:643-8.
7. Clinical Quality Improvement Network Investigators. Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. Arch Intern Med 1996;156:1669-73.
8. Croft JB, Giles WH, Roegner RH, et al. Pharmacologic management of heart failure among older adults by office-based physicians in the United States. J Fam Pract 1997;44:382-90.
9. Hillis GS, Al-Mohammad A, Wood M, et al. Changing patterns of investigation and treatment of cardiac failure in hospital. Heart 1996;76:427-9.
10. Krumholz HM, Wang Y, Parent EM, et al. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med 1997;157:2242-7.
11. The Large State Peer Review Organization Consortium. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. Arch Intern Med 1997;157:1103-8.
12. The SEOSI Investigators. Survey on heart failure in Italian hospital cardiology units: results of the SEOSI study. Eur Heart J 1997;18:1457-64.
13. Missouris CG, MacGregor GA. The use of angiotensin-converting enzyme inhibitors in the treatment of heart failure in hospital practice. Postgrad Med J 1997;73:409-11.
14. Philbin EF, Andreou C, Rocco TA, et al. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol 1996;77:832-8.
15. Philbin EF, Rocco TA. Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function. Am Heart J 1997;134:188-95.
16. Simko RJ, Stanek EJ. Treatment patterns for heart failure in a primary care environment. Am J Man Care 1997;3:1669-76.
17. Young JB, Weiner DH, Yusuf S, et al. Patterns of medication use in patients with heart failure: a report from the registry of studies of left ventricular dysfunction (SOLVD). South Med J 1995;88:514-23.
18. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35.
19. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
20. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669-77.
21. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
22. Tsevat J, Duke D, Goldman L, et al. Cost-effectiveness of captopril therapy after myocardial infarction. J Am Coll Cardiol 1995;26:914-9.
23. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 1986;314:1547-52.
24. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
25. Komajda M, Wimart MC, Thibout E. The ATLAS study (Assessment of Treatment with Lisinopril and Survival): justification and objectives. Arch Mal Coeur Vaiss 1994;87:45-50.
26. Rich MW, Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-5.
27. Moses LE. Measuring effects without randomized trials? Options, problems, challenges. Med Care 1995;33:AS8-14.